A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

References 

1. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon α-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994;330:820–5.
2. Allan NC, Richards SM, Shepherd PCA. UK Medical Research Council randomised, multicentre trial of interferon α n1 for chronic myeloid leukemia: improved survival irrespective of cytogenetic response. Lancet. 1995;345:1392–1397
   • Abstract
   • CrossRef
3. Ohnishi K, Ohno R, Tomonaga M, Kamada N, Onozawa K, Kuramoto A, Dohy H, Mizoguchi H, Miyawaki S, Tsubaki K, Miura Y, Omine M, Kobayashi T, Naoe T, Ohshima T, Hirashima K, Ohtake S, Takahashi I, Morishima Y, Naito K, Asou N, Tanimoto M, Sakuma A, Yamada K, and the Kouseisho Leukemia Study Group. A randomized trial comparing interferon with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase. Blood 1995;86:906–16.
4. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld KK, Queißer W, Löffler H, Hochhaus A, Heinze B, Georgii A, Bartram CR, Greißhammer M, Bergmann L, Essers U, Falge C, Queißer U, Meyer P, Schmitz N, Eimermacher H, Walther F, Fett W, Kleeberg UR, Käbisch A, Nerl C, Zimmermann R, Meuret G, Techelle A, Kanz L, Tigges FJ, Schmid L, Brockhaus W, Tobler A, Reiter A, Perker M, Emmrich B, Verpoort K, Zankovich R, Wussow P, Prümmer O, Thiele J, Buhr T, Carbonell F, Ansari H, and the German CML Study Group. Randomized comparison of interferon α with Busulfan and Hydroxyurea in chronic myelogenous leukemia. Blood 1994;84:4064–77.
5. Chronic Myeloid Leukemia Trialists’ Collaborative Group. Interferon α versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials. J Natl Cancer Inst 1997;89:1616–20.
6. Silver RT, Woolf SH, Hehlmann R, Appelbaum FR, Anderson J, Bennett C, et al.  An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood. 1999;94(5):1517–1536 Review
   • MEDLINE
7. Kantarjian HM, Smith TL, O’Brian S, Beran M, Pierce S, Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy. Ann. Intern. Med. 1995;122(4):254–261
   • MEDLINE
8. Guilhot F, Chastang C, Michalet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J, for the French Chronic Myeloid Leukemia Study Group. Interferon α2b (IFN) and cytarabine (araC) increase survival and cytogenetic response in chronic myeloid leukemia (CML). N Engl J Med 1997;337:223–9.
9. Rosti G, Bonifazi F, Trabacchi E, de Vivo A, Martinelle G, Bassi S, et al.  Results of a national prospective randomized trial comparing interferon and interferon plus low dose cytarabine in early chronic phase chronic myelogenous leukemia: rates of hematological and cytogenetic responses and effects of survival. Haematologica. 2000;85:24
10. Thaler J, Hilbe W for the Austrian CML Study Group. Comparative analysis of two consecutive phase II studies with interferon α and interferon α + araC in untreated chronic-phase CML patients. Bone Marrow Transplant 1996;17(Suppl 3):25–8.
11. Kantarjian HM, O’Brian S, Smith TL, Rios MB, Cortes J, Beran M, et al.  Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon α and low-dose cytarabine. J. Clin. Oncol. 1999;17:284–292
    • MEDLINE
12. Lindauer M, Donkin D, Döhner H, Kolb HJ, Neubauer A, Huhn D, et al.  Efficiacy and toxicity of IFN-α2b combined with cytarabine in chronic myelogenous leukemia. Br. J. Haematol. 1999;106:1013–1019
    • MEDLINE
    • CrossRef
13. Arthur CK, Ma DDF. Combined interferon α-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. Acta Heamatol. 1993;89(Suppl. 1):15–21
14. Kurzrock R, Gutterman JU, Kantarjian H, Talpaz M. Therapy of chronic myelogenous leukemia with interferon. Cancer Invest. 1989;7:83
    • MEDLINE
    • CrossRef
15. Duba HC, Hilbe W, Mehringer A, Erdel M, Thaler J, Utermann G. Hypermetaphase- and interphase fluorescence in situ hybridisation (FISH) for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukemia. Int. J. Oncol. 2000;17(6):1245–1249
    • MEDLINE
16. Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, et al.  A prospective randomized study of α-2b Interferon plus Hydroxyurea or Cytarabine for patients with early chronic phase chronic myelogenous leukemia: The International Oncology Study Group CML1 Study. Leukemia Lymphoma. 2000;37(3/4):367–377